FKBP10 Inhibitors

FKBP10 inhibitors belong to a specialized class of chemical compounds designed to target the FKBP10 (FK506-Binding Protein 10) protein. FKBP10 is a member of the FKBP family, which includes a group of peptidyl-prolyl isomerases (PPIases) known for their role in protein folding and trafficking. FKBP10, also referred to as FKBP65, is unique among the FKBP family members due to its predominantly endoplasmic reticulum (ER) localization and its involvement in the post-translational modification of collagen. Collagen is a major structural protein in the extracellular matrix and is essential for maintaining the integrity of various tissues, including skin, bone, and connective tissues. Inhibitors of FKBP10 are designed to interact with this protein and disrupt its peptidyl-prolyl isomerase activity or other functions related to collagen metabolism. These inhibitors may operate through various mechanisms, such as binding to specific domains of FKBP10 or altering its conformation. By inhibiting FKBP10, these compounds can interfere with the proper folding and modification of collagen, which may have downstream effects on the structure and function of connective tissues and extracellular matrix components. Research on FKBP10 inhibitors is primarily focused on elucidating the molecular mechanisms by which FKBP10 contributes to collagen biology and tissue integrity, offering insights into the complex processes involved in tissue development and maintenance.